Use UNICORN Signals App By EquityPandit

Tag : Concert Pharmaceuticals

Sun Pharma Among Nifty’s Biggest Losers After USFDA Put Partial Clinical Trial on Deuruxolitinib Drug

NileshMay 2, 2023May 2, 2023

by NileshMay 2, 2023May 2, 202302088

Shares of Sun Pharmaceutical Industries fell more than 1% on May 2 after the US Food and Drug Administration (USFDA) suspended part of its clinical...

BUSINESS

Sun Pharma Completes Acquisition of Concert Pharmaceuticals

NileshMarch 7, 2023March 7, 2023

by NileshMarch 7, 2023March 7, 202301935

On Monday, pharmaceutical giant Sun Pharma said it had completed its acquisition of US-based Concert Pharmaceuticals. In January, the Mumbai-based company signed a deal to...

BUSINESS

Sun Pharma Acquires Concert for $576 Million

NileshJanuary 20, 2023January 20, 2023

by NileshJanuary 20, 2023January 20, 202302029

Sun Pharmaceutical Industries, the world’s fourth largest speciality generic drug company, has signed a definitive agreement to acquire US-based Concert Pharmaceuticals for $576 million in...

Latest
IPO

Weekly
Outlook

Stock

Market
Prediction